UNITED THERAPEUTICS Corp Annual Interest Expense in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
UNITED THERAPEUTICS Corp quarterly/annual Interest Expense history and growth rate from 2010 to 2023.
  • UNITED THERAPEUTICS Corp Interest Expense for the quarter ending March 31, 2024 was $13.3M, a 3.62% decline year-over-year.
  • UNITED THERAPEUTICS Corp Interest Expense for the twelve months ending March 31, 2024 was $58.8M, a 41.7% increase year-over-year.
  • UNITED THERAPEUTICS Corp annual Interest Expense for 2023 was $59.3M, a 83% increase from 2022.
  • UNITED THERAPEUTICS Corp annual Interest Expense for 2022 was $32.4M, a 74.2% increase from 2021.
  • UNITED THERAPEUTICS Corp annual Interest Expense for 2021 was $18.6M, a 20.9% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $59.3M +$26.9M +83% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-21
2022 $32.4M +$13.8M +74.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-21
2021 $18.6M -$4.9M -20.9% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-21
2020 $23.5M -$20.7M -46.8% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-22
2019 $44.2M +$30.3M +218% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 $13.9M +$4.9M +54.4% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-24
2017 $9M +$5.1M +131% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-26
2016 $3.9M -$800K -17% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-27
2015 $4.7M -$12.9M -73.3% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-21
2014 $17.6M -$458K -2.54% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-22
2013 $18.1M +$1.42M +8.53% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-25
2012 $16.6M -$4.73M -22.1% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-24
2011 $21.4M +$1.66M +8.41% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-25
2010 $19.7M Jan 1, 2010 Dec 31, 2010 10-K 2013-02-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.